Stable Isotope Labelled Lirilumab Biosimilar – Anti-KIRD2 subgroup mAb – Research Grade

Reference: PX-TA1297-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Lirilumab Biosimilar - Anti-KIRD2 subgroup mAb - Research Grade
SourceCAS 1000676-41-4
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsBMS-986015,IPH2102
ReferencePX-TA1297-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeHuman IgG1
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Lirilumab Biosimilar - Anti-KIRD2 subgroup mAb - Research Grade

General information on Anti-KIRD2 subgroup[Homo sapiens] (Lirilumab) Monoclonal Antibody

Lirilumab has been investigated for the treatment of Leukemia, Cancer, Multiple Myeloma, Lymphocytic Leukemia, and Acute Myeloid Leukemia.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Lirilumab Biosimilar – Anti-KIRD2 subgroup mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products